Journal article · 2026 · Open access
Implementation of Pharmacogenomics in Pediatric‐Focused Institutions Within the Pharmacogenomics Global Research Network
Clinical Pharmacology & Therapeutics · Published 7 November 2026 · DOI 10.1002/cpt.70553
In brief
“Implementation of Pharmacogenomics in Pediatric‐Focused Institutions Within the Pharmacogenomics Global Research Network” is a 2026 journal article by Laura B. Ramsey and 15 co-authors, published in Clinical Pharmacology & Therapeutics. OpenAlex counts 0 citations as of 16 November 2026. It is open access under a CC BY-NC-ND licence: the full text is free to read at Clinical Pharmacology & Therapeutics.
- Citations
- 0
- References
- 39
- Authors
- 16
Abstract
Descriptions of how pediatric-focused institutions implement pharmacogenomic testing are scarce, and often not differentiated from adult-focused institutions. We aimed to provide a detailed description of how pediatric-focused institutions across the world implemented pharmacogenomic testing in clinical practice. A survey was distributed to members of the Pharmacogenomics Global Research Network to assess program infrastructure, implementation efforts, genes tested, method of testing, and clinical decision support. The survey was completed by 43 institutions that have implemented pharmacogenomics: 12 pediatric-focused, 10 adult-focused, and 21 institutions serving all ages. All pediatric-focused institutions provide testing for CYP2C19, CYP2C9, CYP2D6, CYP3A5, NUDT15, and TPMT. Psychiatry and hematology/oncology were the specialties most commonly reported as implementing pharmacogenomics at pediatric-focused institutions. Most institutions have clinical decision support incorporated into their electronic health record and a similar number of compensated employees contributing to the program, regardless of age group focus. All pediatric-focused institutions were non-profit and often received programmatic funding from internal sources. A higher proportion of pediatric-focused sites provided patient education (92%) compared to adult-focused (60%) and those caring for all ages (76%). Pediatric-focused institutions interested in implementing or expanding their pharmacogenomic services will encounter many of the same opportunities and considerations as adult institutions. The results of this survey highlight additional unique considerations for pediatric-focused pharmacogenomic implementation and may serve as a roadmap for pediatric institutions interested in implementing or expanding pharmacogenomic services.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Ramsey, L. B., Bousman, C., van den Brand, R., Cook, K. J., Gregornik, D. B., Haidar, C. E., Hakooz, N., Keuler, N. L., Lamb, N., Nagy, M., Nguyen, J. Q., Paetznick, C., Schultz, A., Smith, D. M., Tsermpini, E. E., & Elchynski, A. L. (2026). Implementation of Pharmacogenomics in Pediatric‐Focused Institutions Within the Pharmacogenomics Global Research Network. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70553
MLA 9
Ramsey, Laura B., et al. “Implementation of Pharmacogenomics in Pediatric‐Focused Institutions Within the Pharmacogenomics Global Research Network.” Clinical Pharmacology & Therapeutics, 2026. https://doi.org/10.1002/cpt.70553.
Chicago
Ramsey, Laura B., Chad Bousman, Rebecca van den Brand, Kelsey J. Cook, David B. Gregornik, Cyrine E. Haidar, Nancy Hakooz, et al. 2026. “Implementation of Pharmacogenomics in Pediatric‐Focused Institutions Within the Pharmacogenomics Global Research Network.” Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70553.
Harvard
Ramsey, L. B. et al. (2026) ‘Implementation of Pharmacogenomics in Pediatric‐Focused Institutions Within the Pharmacogenomics Global Research Network’, Clinical Pharmacology & Therapeutics. doi:10.1002/cpt.70553.
IEEE
L. B. Ramsey et al., “Implementation of Pharmacogenomics in Pediatric‐Focused Institutions Within the Pharmacogenomics Global Research Network,” Clinical Pharmacology & Therapeutics, 2026, doi: 10.1002/cpt.70553.
BibTeX
@article{ramsey2026implementation,
title = {{Implementation of Pharmacogenomics in Pediatric‐Focused Institutions Within the Pharmacogenomics Global Research Network}},
author = {Ramsey, Laura B. and Bousman, Chad and van den Brand, Rebecca and Cook, Kelsey J. and Gregornik, David B. and Haidar, Cyrine E. and Hakooz, Nancy and Keuler, Nicole L. and Lamb, Nathan and Nagy, Mohamed and Nguyen, Jenny Q. and Paetznick, Courtney and Schultz, April and Smith, D. Max and Tsermpini, Evangelia Eirini and Elchynski, Amanda L.},
journal = {Clinical Pharmacology \& Therapeutics},
year = {2026},
doi = {10.1002/cpt.70553},
url = {https://doi.org/10.1002/cpt.70553}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- clinical decision support
- electronic health records
- CYP2C19
- CYP2C9
- CYP2D6
- CYP3A5
- NUDT15
- thiopurine S-methyltransferase
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Ramsey, L. B., Bousman, C., van den Brand, R., Cook, K. J., Gregornik, D. B., Haidar, C. E., Hakooz, N., Keuler, N. L., Lamb, N., Nagy, M., Nguyen, J. Q., Paetznick, C., Schultz, A., Smith, D. M., Tsermpini, E. E., & Elchynski, A. L. (2026). Implementation of Pharmacogenomics in Pediatric‐Focused Institutions Within the Pharmacogenomics Global Research Network. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70553
How many times has this paper been cited?
0 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Clinical Pharmacology & Therapeutics: sign in and open the PDF from this page.
Who wrote this paper?
Laura B. Ramsey, Chad Bousman, Rebecca van den Brand, Kelsey J. Cook, David B. Gregornik, Cyrine E. Haidar, Nancy Hakooz, Nicole L. Keuler, Nathan Lamb, Mohamed Nagy, Jenny Q. Nguyen, Courtney Paetznick and 4 more.
What is the DOI of this paper?
10.1002/cpt.70553, permanently at https://doi.org/10.1002/cpt.70553. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.